Ann: Quarterly Update and Appendix 4C, page-19

So now you tell me that even you have never mentioned before when you made your account estimate (which by the way is quite close but higher) it included the manufacturing’s prepayment of the drug.
Wow I have to admit you are the best “glass ball” financial adviser I came across hilarious sometimes but
efficient or sort of.
Efficient or inefficient ? Regardless all your bashing you claim to be on the top 20 holders so bashing but confident a position somewhat from extremely opposite point. Well can you do us a favour and read your glass ball and let us know if you can see anything just anything positive in the company ? Or the reason of your frequent posting (negative of course) is due to the fact that you don’t have anything to keep you occupied and your provocative posts keeps you in an enjoyable occupation reading (and maybe laughing) others posters reply. Relax Akki and have a nice week end away from key board.